Since we have recently shown that TTR is present in ascitic fluid [24], it cannot be excluded that its presence might not only arise from an increased permeability for blood constituents into ascitic fluid due to an intensified vascularization [25], but may also reflect the secretion of products synthesized by the malignant ovary cells due to the intimate contact between tumor site and ascitic fluid. Here, TTR is linked to neoplasm.